<SEC-DOCUMENT>0000929638-18-000055-index.html : 20180122
<SEC-HEADER>0000929638-18-000055.hdr.sgml : 20180122
<ACCEPTANCE-DATETIME>20180122160321
ACCESSION NUMBER:		0000929638-18-000055
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20180122
DATE AS OF CHANGE:		20180122
GROUP MEMBERS:		BIHUA CHEN
GROUP MEMBERS:		CORMORANT GLOBAL HEALTHCARE GP, LLC
GROUP MEMBERS:		CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mirati Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001576263
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462693615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-87670
		FILM NUMBER:		18539907

	BUSINESS ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-332-3410

	MAIL ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cormorant Asset Management, LLC
		CENTRAL INDEX KEY:			0001583977
		IRS NUMBER:				462108927
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		STREET 2:		52ND FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		857-702-0388

	MAIL ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		STREET 2:		52ND FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>schedule13g.htm
<TEXT>
Document 1 - file: schedule13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit00-1.htm
<TEXT>
Document 2 - file: exhibit00-1.htm

</DOCUMENT>
</SEC-DOCUMENT>